Anti-ZNF407 monoclonal antibody

Pre-made anti-ZNF407 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZNF407/ZNF407 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2832-Ab-1/ GM-Tg-hg-IP2832-Ab-2Anti-Human ZNF407 monoclonal antibodyHuman
GM-Tg-rg-IP2832-Ab-1/ GM-Tg-rg-IP2832-Ab-2Anti-Rat ZNF407 monoclonal antibodyRat
GM-Tg-mg-IP2832-Ab-1/ GM-Tg-mg-IP2832-Ab-2Anti-Mouse ZNF407 monoclonal antibodyMouse
GM-Tg-cynog-IP2832-Ab-1/ GM-Tg-cynog-IP2832-Ab-2Anti-Cynomolgus/ Rhesus macaque ZNF407 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2832-Ab-1/ GM-Tg-felg-IP2832-Ab-2Anti-Feline ZNF407 monoclonal antibodyFeline
GM-Tg-cang-IP2832-Ab-1/ GM-Tg-cang-IP2832-Ab-2Anti-Canine ZNF407 monoclonal antibodyCanine
GM-Tg-bovg-IP2832-Ab-1/ GM-Tg-bovg-IP2832-Ab-2Anti-Bovine ZNF407 monoclonal antibodyBovine
GM-Tg-equg-IP2832-Ab-1/ GM-Tg-equg-IP2832-Ab-2Anti-Equine ZNF407 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2832-Ab-1/ GM-Tg-hg-IP2832-Ab-2; GM-Tg-rg-IP2832-Ab-1/ GM-Tg-rg-IP2832-Ab-2;
GM-Tg-mg-IP2832-Ab-1/ GM-Tg-mg-IP2832-Ab-2; GM-Tg-cynog-IP2832-Ab-1/ GM-Tg-cynog-IP2832-Ab-2;
GM-Tg-felg-IP2832-Ab-1/ GM-Tg-felg-IP2832-Ab-2; GM-Tg-cang-IP2832-Ab-1/ GM-Tg-cang-IP2832-Ab-2;
GM-Tg-bovg-IP2832-Ab-1/ GM-Tg-bovg-IP2832-Ab-2; GM-Tg-equg-IP2832-Ab-1/ GM-Tg-equg-IP2832-Ab-2
Products NameAnti-ZNF407 monoclonal antibody
Formatmab
Target NameZNF407
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZNF407 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2832-Ag-1Recombinant multi-species ZN407/ ZNF407 protein


    Target information

    Target IDGM-IP2832
    Target NameZNF407
    Gene ID55628,240476,307213,695303,476164,101096175,530360,100052274
    Gene Symbol and Synonyms6430585N13Rik,Gm333,Gm334,Gm948,RGD1310645,SIMHA,Zfp407,ZNF407
    Uniprot AccessionQ9C0G0
    Uniprot Entry NameZN407_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000215421
    Target ClassificationN/A

    The target: ZNF407, gene name: ZNF407, also named as . This gene encodes a zinc finger protein whose exact function is not known. It may be involved in transcriptional regulation. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.